Provided by Tiger Trade Technology Pte. Ltd.

Vector Acquisition Corporation II

10.67
0.0000
Volume:- -
Turnover:- -
Market Cap:173.46M
PE:50.23
High:10.67
Open:10.67
Low:10.67
Close:10.67
52wk High:10.67
52wk Low:10.67
Shares:16.26M
Float Shares:2.81M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2124
EPS(LYR):0.1011
ROE:--
ROA:-0.29%
PB:-10.21
PE(LYR):105.51

Loading ...

Vector (NZSE:VCT) Reports Electricity Growth, Is The Stock Fully Valued?

Simply Wall St.
·
Jul 24

Unity Software's Q2 Results Likely In Line With Expectations, Wedbush Securities Says

MT Newswires Live
·
Jul 22

Vector Reports Higher Electricity Network Connections in Fiscal Year 2026, Gas Connections Decline

MT Newswires Live
·
Jul 22

Vector posts solid electricity growth as gas network contracts and reliability improves

TIPRANKS
·
Jul 22

Vector Sets September 2026 Date for Annual Shareholder Meeting

TIPRANKS
·
Jul 22

Vector sets August date for 2026 full-year results webcast

TIPRANKS
·
Jul 17

Vector Inc 6058 Sees 1H Net Y2.60b

Dow Jones
·
Jul 15

Press Release: Vector Science & Therapeutics Names Dexter Fowler as Chief Athletic Officer for Its Valor Platform

Dow Jones
·
Jun 12

Press Release: Vector Science & Therapeutics Appoints Darryl Drake Jr. as President of Valor

Dow Jones
·
Jun 08

Vector Science & Therapeutics Grants 206,000 Stock Options to Directors Amid Strategic Growth Push

Deep News
·
Jun 02

Vector to Retain Ownership of Fibre Business Following Strategic Review

MT Newswires Live
·
Jun 02

Bank of Montreal renews five-year partnership with Vector Institute

TIPRANKS
·
May 29

Rapid7 Q1 2026 Threat Landscape Report Finds Vulnerability Exploitation Overtakes Social Engineering as the Top Initial Access Vector

GlobeNewswire
·
May 21

Vector Inc. Books Large Intra-Group Dividends Without Impacting Consolidated Earnings

TIPRANKS
·
May 20

Vector Inc 2656 FY Loss Y549.00M Vs Loss Y779.00M

Dow Jones
·
May 15

Press Release: Vector Science & Therapeutics Agrees to an Option to Invest in LyoGenesis Plus, Securing Long-Term Access to FDA-Registered, cGMP Manufacturing

Dow Jones
·
May 13

Press Release: Vector Science & Therapeutics Expands Board of Directors with Appointment of Dr. Alexander Dobranowski and Scott Kelly

Dow Jones
·
May 06

Assessing Vector (NZSE:VCT) Valuation After Solid Electricity Growth And Softer Gas Metrics

Simply Wall St.
·
May 03

Press Release: Vector Science & Therapeutics Announces Tommy Thompson as Chairman of the Board

Dow Jones
·
Apr 30

Siegfried’s DINAMIQS Wins Swissmedic License, Expanding Viral Vector CDMO Capabilities

TIPRANKS
·
Apr 29